Previous Page  3 / 38 Next Page
Information
Show Menu
Previous Page 3 / 38 Next Page
Page Background

J u n e 1 1 - 1 3 , 2 0 1 8 | D u b l i n , I r e l a n d

allied

academies

Page 21

Note:

CANCER STEM CELLS AND

ONCOLOGY RESEARCH

11

th

International Conference on

Journal of Medical Oncology and Therapeutics

|

Volume 3

Guo-fu Hu et al., J Med Oncl Ther 2018, Volume 3

ANGIOGENIN AND PLEXIN-B2

INHIBITION SENSITIZES PROSTATE

CANCER STEM CELLS TO

CHEMOTHERAPY

Guo-fu Hu

1,2

, Shuping Li

1

, Kevin A Goncalves

1,2

and

Baiqing

Lyu

1

1

Tufts Medical Center, Washington, USA

2

Tufts University, Medford, USA

A

ngiogenin (ANG) and its receptor Plexin-B2 (PLXNB2) has recently

been shown todichotomously regulate the stemnessof hematopoietic

stem and progenitor cells (HSPC). While

ANG

and PLXNB2 preserve

quiescence of the primitive stem cells, they promote proliferation of more

differentiated progenitor cells. Here we show that ANG-PLXNB2 also

dichotomously regulates the properties of cancer stem cells (CSC) and

differentiated bulk cancer cells. Prostate CSCs were cloned from PC3,

LNCaP, and DU145 cells, and shown to have self-renewal, differentiation,

and tumor-initiating capacities. While ANG-PLXNB2 enhance proliferation

of differentiated prostate cancer cells, they restrict proliferation of

CSCs and promote quiescence through specific cleavage of 5S rRNA.

Monoclonal antibodies against both ANG and PLXNB2 were found to

mobilize CSC out of quiescence, sensitive them to chemotherapy, and

prevent disease relapse.

Guo-fu Hu, PhD, is currently a Professor of Med-

icine, Tufts University School of Medicine, and

an Investigator at Tufts Medical Center. He re-

ceived his PhD from Shanghai Institute ofBio-

chemistry, Chinese Academy of Sciences, and

did his postdoctoral training in Beret L. Vallee

lab located at the Center for Biochemical and

Biophysical Sciences and Medicine, Harvard

Medical School. He established his research

program first in the Department of Radiology,

Brigham and Women’s Hospital, and then in

the Department of Pathology, Harvard Medical

School, where he raised to the rank of Associate

Professor of Pathology. He moved to Tufts Med-

ical Center in 2010.

guo-fu.hu@tufts.edu

BIOGRAPHY